DWA
CLMT icon

Dorsey Wright & Associates’s Calumet Specialty Products CLMT Stock Holding History

Dorsey Wright & Associates’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$78K Sell
7,484
-459
-6% -$6.1K 0.02% 115
2022
Q1 		$108K Sell
7,943
-1,071
-12% -$15.8K 0.03% 121
2021
Q4 		$119K Buy
9,014
+1,224
+16% +$15.4K 0.02% 131
2021
Q3 		$62K Buy
7,790
+612
+9% +$4.21K 0.01% 168
2021
Q2 		$49K Buy
+7,178
New +$44.3K 0.01% 196

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return
BCM
Bienville Capital Management New York $550M AUM 3.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dorsey Wright & Associates's CLMT Position: Q2 2022 in Review

Dorsey Wright & Associates reduced its Calumet Specialty Products (CLMT) stake by 5.8% in Q2 2022, selling an estimated $6.1K and leaving 7,484 shares worth $78K. The position accounts for 0.02% of the portfolio, ranked #115.

Dorsey Wright & Associates first reported a position in CLMT in Q2 2021 and has held it in 5 quarters since. The position peaked at $119K in Q4 2021. 65 funds tracked by Wall St. Rank hold CLMT as of Q2 2022.

  • Dorsey Wright & Associates held 7,484 shares of Calumet Specialty Products worth $78K as of Q2 2022.
  • Dorsey Wright & Associates sold 459 Calumet Specialty Products shares in Q2 2022, an estimated $6.1K.
  • Calumet Specialty Products made up 0.02% of Dorsey Wright & Associates's portfolio in Q2 2022, its #115 holding.
  • Dorsey Wright & Associates first reported a position in Calumet Specialty Products in Q2 2021 and has held it in 5 quarters since.
  • Dorsey Wright & Associates's Calumet Specialty Products position peaked at $119K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2022.

Based on Dorsey Wright & Associates's 13F filing for Q2 2022, filed 20 Jul 2022.